Anxiety disorders in familial parkinsonism.
Anxiety disorders in familial parkinsonism.
复制标题
家族性帕金森症的焦虑症。
DOI:
10.1002/anxi.3070010505
复制
发表时间:
1991
期刊:
影响因子:
--
通讯作者:
R. Duvoisin
中科院分区:
文献类型:
--
作者:
E. Lauterbach;R. Duvoisin
We examined neuroendocrine correlates of central monoamine function in patients with the generalized type of social phobia compared to healthy volunteers in order to test hypotheses of dopaminergic, noradrenergic, and/or serotonergic dysregulation in patients with this disorder.A double‐blind, placebo‐controlled, neuropharmacological challenge study was performed using probes for the serotonergic (fenfluramine), dopaminergic (levodopa), and noradrenergic (clonidine) systems.Twenty‐one patients with DSM‐III‐R social phobia (generalized type) and 22 “never mentally ill” volunteers participated in the study after providing informed consent.Patients with social phobia had an augmented cortisol response to fenfluramine administration compared to the volunteers. In contrast, we found that neither the prolactin response to fenfluramine, the growth hormone or norepinephrine response to clonidine, nor the prolactin or eye‐blink responses to levodopa, differed between patients with social phobia and healthy volunteers.The findings suggest that patients with social phobia may exhibit selective super‐sensitivity of serotonergic systems, but that dopaminergic and noradrenergic Junction appear normal. Further challenge studies with more specific serotonin probes before and after treatment may assist in the clarification of the pathophysiology of social phobia. Anxiety 1:216–223 (1994/1995). © 1995 Wiley‐Liss, Inc.